Cite
Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7.
MLA
Gong, Minmin, et al. “Trigonelline Inhibits Tubular Epithelial-Mesenchymal Transformation in Diabetic Kidney Disease via Targeting Smad7.” Biomedicine & Pharmacotherapy, vol. 168, Dec. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115747.
APA
Gong, M., Guo, Y., Dong, H., Wu, W., Wu, F., & Lu, F. (2023). Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7. Biomedicine & Pharmacotherapy, 168, N.PAG. https://doi.org/10.1016/j.biopha.2023.115747
Chicago
Gong, Minmin, Yujin Guo, Hui Dong, Wenbin Wu, Fan Wu, and Fuer Lu. 2023. “Trigonelline Inhibits Tubular Epithelial-Mesenchymal Transformation in Diabetic Kidney Disease via Targeting Smad7.” Biomedicine & Pharmacotherapy 168 (December): N.PAG. doi:10.1016/j.biopha.2023.115747.